
- Telehealth Visits
- Insurance plan information


Jill L. Ostrem, MD
Neurology • Pediatric NeurologyMedical Director and Division Chief, UCSF Movement Disorders and Neuromodulation Center- Telehealth Visits
- Insurance plan information




Jill L. Ostrem, MD
Neurology • Pediatric NeurologyMedical Director and Division Chief, UCSF Movement Disorders and Neuromodulation Center- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Jill Ostrem is a neurologist with a special interest in treating movement disorders, including Parkinson's disease, dystonia and essential tremor. She is medical director and division chief of the UCSF Movement Disorders and Neuromodulation Center.
Ostrem's research focuses on improving diagnosis, experimental therapeutics and technical innovations in surgery treatments for movement disorders. She works to develop improved deep brain stimulation (DBS) systems – implanted devices that deliver electrical impulses to treat movement disorders– and investigates optimal DBS brain targets. She also studies innovations in patient care, including telehealth – providing health care through advanced technologies – and new models for palliative care.
Ostrem earned her medical degree from the George Washington University. She completed a residency in neurology and a fellowship in movement disorders at the Ronald Reagan UCLA Medical Center.
After joining UCSF in 2003, Ostrem helped establish its internationally recognized clinical, research and training center for the treatment of movement disorders. The center has a long history and expertise in treating Parkinson's disease and dystonia with DBS. Ostrem is a member of the American Neurological Association, American Academy of Neurology and International Parkinson and Movement Disorder Society.
Education & training
Board certification
- Neurology, American Board of Psychiatry/Neurology-Psychiatry
Residency
- University of California Los Angeles
Internship
- Washington Hospital
Degree
- MD, George Washington University School of Medicine
Academic title
- Clinical Professor
My expertise
Specialties
- Neurology
- Pediatric Neurology
- Neurology (Movement Disorders)
Conditions
- Tardive Dyskinesia
- Spasticity
- Progressive Supranuclear Palsy
- Multiple System Atrophy
- Lewy Body Dementia
- Huntington's Disease
- Dystonia
- Parkinson's Disease (PD)
- Movement Diseases and Disorders
Treatments
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%221008%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=start_date_dt+asc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%221008%22%29&rows=4&sort=date_published+asc&fq=content_type%3A%22Publication%22
Showing 1-6 of 20 reviews
- July 26, 20265 out of 5 Stars
Dr Ostrem was extremely thoughtful and thorough in her remarks. I have seen a couple of other doctors and learned more from 1 hour with Dr Ostrem than I did in multiple appointments with others.
- May 3, 20265 out of 5 Stars
All great.
- April 29, 20265 out of 5 Stars
Dr. Ostrem is an exceptional individual that practices medicine.
- February 24, 20265 out of 5 Stars
BEST SERVICE! WE FEEL VERY SUPPORTED!
- February 18, 20265 out of 5 Stars
Dr. Jill Ostrem is one of a kind! She has the bright shining light in my life! She has an excellent position with amazing presence and patient care skills
- November 14, 20255 out of 5 Stars
Dr. Ostrem is truly outstanding in every category. She has wonderful but rare combination of being a leader in her field and possessing a genuine, caring, compassionate spirit. You could not have a better brand ambassador for your top-tier organization. And I pinch myself that I am her patient. She is truly the BEST!
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.